M. Kryjewski et al. / Inorganic Chemistry Communications 27 (2013) 56–59
59
[19] N.C.L. Zeballos, M.C.G. Vior, J. Awruch, L.E. Dicelio, An exhaustive study of a novel
sulfur-linked adamantane tetrasubstituted zinc(II) phthalocyanine incorporated
into liposomes, J. Photochem. Photobiol. A 235 (2012) 7–13.
[20] D. Wöhrle, M. Eskes, K. Shigehara, A. Yamada, A simple synthesis of 4,5-disubsti-
tuted 1,2-dicyanobenzenes and 2,3,9,10,16,17,23,24-octasubstituted phthalocya-
nines, Synthesis (1993) 194–196.
[21] Preparation of compound 3: 1 (0.591 g, 3.00 mmol) and 2 (1.262 g, 7.50 mmol)
were dissolved in DMF (18 mL), next K2CO3 (4.14 g, 30 mmol) was added in two
portions and the reaction mixture was stirred for 20 h at room temperature. After
that time the reaction mixture was poured into ice-water. The resulting solid was fil-
tered, washed with water, dried, taken into reflux in CH3OH (20 mL) for 30 min in
order to remove soluble impurities. Pale yellow amorphous solid (1.370 g, 99%)
was obtained. M.p. 219–221 °C. Rf=0.46 (n-hexane:EtOAc 7:1). Anal. Calc. for
References
[1] G. de la Torre, P. Vázquez, F. Agulló-López, T. Torres, Role of structural factors in the
nonlinear optical properties of phthalocyanines and related compounds, Chem. Rev.
104 (2004) 3723–3750.
[2] İ. Özçeşmeci, I. Sorar, A. Gül, Zinc(II)phthalocyanine as an optical window for vis-
ible region, Inorg. Chem. Commun. 14 (2011) 1254–1257.
[3] Y. Liu, H. Lin, X. Li, J. Li, H. Nan, Photoinduced electron transfer in panchromatic
zinc phthalocyanine–azobenzene dyad, Inorg. Chem. Commun. 13 (2010)
187–190.
[4] M.V. Martínez-Díaz, M. Ince, T. Torres, Phthalocyanines: colorful macroheterocyclic
sensitizers for dye-sensitized solar cells, Monatsh. Chem. 142 (2011) 699–707.
[5] A.E. O'Connor, W.M. Gallagher, A.T. Byrne, Porphyrin and nonporphyrin photo-
sensitizers in oncology: preclinical and clinical advances in photodynamic thera-
py, Photochem. Photobiol. 85 (2009) 1053–1074.
[6] S. Yano, S. Hirohara, M. Obata, Y. Hagiya, S. Ogura, A. Ikeda, H. Kataoka, M. Tanaka,
T. Joh, Current states and future views in photodynamic therapy, J. Photochem.
Photobiol. C 12 (2011) 46–67.
[7] R.R. Allison, C.H. Sibata, Oncologic photodynamic therapy photosensitizers: a
clinical review, Photodiagn. Photodyn. Ther. 7 (2010) 61–75.
C
28H32N2S2: C, 73.00; H, 7.00; N, 6.08; S, 13.92. Found: C, 72.88; H, 7.00; N, 6.06; S,
14.01.1H NMR (400 MHz, DMSO-d6) δ=8.15 (s, 2H), 2.02 (bs, 6H), 1.89 (bs, 12H),
1.63 (bs, 12H). 13C NMR (101 MHz, DMSO-d6) δ=144.8, 139.0, 115.4, 112.8, 52.1,
42.90, 35.3, 29.5. MS (ES) 483 [M+Na]+, 499 [M+K]+
.
[22] T.P. Forsyth, D.B.G. Williams, A.G. Montalban, C.L. Stern, A.G.M. Barrett, B.M.
Hoffman, facile and regioselective synthesis of trans-heterofunctionalized
A
porphyrazine derivatives, J. Org. Chem. 63 (1998) 331–336.
[23] Preparation of compound 5: magnesium (88 mg, 3.63 mmol) with catalytic amount
of iodine was heated under reflux in n-butanol (30 mL) for 5 h. After the mixture was
cooled to room temperature, the phthalonitriles 3 (150 mg, 0.33 mmol) and 4
(423 mg, 3.30 mmol) were added. Reaction mixture was stirred under reflux for 19
h. After, the reaction mixture was Celite filtered and n-butanol was co-evaporated
with toluene (azeotropic behavior, 2×50 mL) to give solid residue. Flash column
chromatography was performed in normal (CH2Cl2:CH3OH 10:1) and reversed
phase (THF:CH3OH 1:4) systems to give 5 as a thin blue-green film (14 mg, 5%).
[8] P. Zimcik, V. Novakova, K. Kopecky, M. Miletin, R.Z. Uslu Kobak, E. Svandrlikova, L.
Váchová, K. Lang, Magnesium azaphthalocyanines: an emerging family of excel-
lent red-emitting fluorophores, Inorg. Chem. 51 (2012) 4215–4223.
[9] T. Goslinski, T. Osmalek, K. Konopka, M. Wierzchowski, P. Fita, J. Mielcarek,
Photophysical properties and photocytotoxicity of novel phthalocyanines - potentially
useful for their application in photodynamic therapy, Polyhedron 30 (2011)
1538–1546.
[10] J. Liu, D. Obando, V. Liao, T. Lifa, R. Codd, The many faces of the adamantyl group
in drug design, Eur. J. Med. Chem. 46 (2011) 1949–1963.
[11] A.Y. Tolbin, A.Y. Sukhorukov, S.L. Ioffe, O.A. Lobach, D.N. Nosik, L.G. Tomilova, Syn-
thesis of a phthalocyanine–1,4,6,10-tetraazaadamantane conjugate and its activ-
ity against the human immunodeficiency virus, Mendeleev Commun. 20 (2010)
25–27.
[12] A.L. Ochoa, T.C. Tempesti, M.B. Spesia, M.E. Milanesio, E.N. Durantini, Synthesis
and photodynamic properties of adamantylethoxy Zn(II) phthalocyanine deriva-
tives in different media and in human red blood cells, Eur. J. Med. Chem. 50
(2012) 280–287.
[13] X.M. Shen, X.J. Jiang, C.C. Huang, H.H. Zhang, J.D. Huang, Highly photostable
silicon(IV) phthalocyanines containing adamantane moieties: synthesis, struc-
ture, and properties, Tetrahedron 66 (2010) 9041–9048.
[14] N. Kobayashi, T. Ohya, M. Sato, S. Nakajima, Synthesis and spectroscopic properties
of symmetrically tetrasubstituted phthalocyanines with four alkyl or aryl chains or
porphyrin, adamantane, crown, or quinone units attached, Inorg. Chem. 32 (1993)
1803–1808.
[15] S.D.P. Baugh, Z. Yang, D.K. Leung, D.M. Wilson, R. Breslow, Cyclodextrin dimers as
cleavable carriers of photodynamic sensitizers, J. Am. Chem. Soc. 123 (2001)
12488–12494.
UV–Vis (DMF): λmax,
nm (logε) 351 (4.49), 685 (4.85). 1H NMR (500 MHz,
pyridine-d5) δ=10.32 (s, 2H), 9.79-9.80 (m, 2H), 9.70-9.73 (m, 2H), 9.67-9.70 (m,
2H), 8.17 – 8.24 (m, 6H), 2.35 (s, 12H), 1.92 (bs, 6H), 1.54 (pq, 12H). 13C NMR (125
MHz, pyridine-d5) δ=155.1, 155.0, 154.3, 152.9, 139.8, 139.6, 139.5, 139.5, 138.6,
133.1, 129.8, 129.7, 129.6, 123.3, 123.3, 123.3 (hidden), 51.1, 44.1, 36.1, 30.3. MS
(MALDI) 869.5 [M+H]+
.
[24] T. Goslinski, T. Osmalek, J. Mielcarek, Photochemical and spectral characterization
of peripherally modified porphyrazines, Polyhedron 28 (2009) 3839–3843.
[25] I. Seotsanyana-Mokhosi, N. Kuznetsova, T. Nyokong, Photochemical studies of
tetra-2,3-pyridinoporphyrazines, J. Photochem. Photobiol. A 140 (2001) 215–222.
[26] W. Spiller, H. Kliesch, D. Wöhrle, S. Hackbarth, B. Röder, G. Schnurpfeil, Singlet ox-
ygen quantum yields of different photosensitizers in polar solvents and micellar
solutions, J. Porphyrins Phthalocyanines 2 (1998) 145–158.
[27] W. Szczolko, L. Sobotta, P. Fita, T. Koczorowski, M. Mikus, M. Gdaniec, A. Orzechowska,
K. Burda, S. Sobiak, M. Wierzchowski, J. Mielcarek, E. Tykarska, T. Goslinski, Synthesis,
characteristics and photochemical studies of novel porphyrazines possessing periph-
eral 2,5-dimethylpyrrol-1-yl and dimethylamino groups, Tetrahedron Lett. 53 (2012)
2040–2044.
[28] A. Ogunsipe, D. Maree, T. Nyokong, Solvent effects on the photochemical and
fluorescence properties of zinc phthalocyanine derivatives, J. Mol. Struct. 650
(2003) 131–140.
[29] N.S. Bayliss, The effect of the electrostatic polarization of the solvent on electronic
absorption spectra in solution, J. Chem. Phys. 18 (1950) 292–296.
[16] P.W. Causey, I. Dubovyk, C.C. Leznoff, Syntheses and characterization of phthalonitriles
and phthalocyanines substituted with adamantane moieties, Can. J. Chem. 84 (2006)
1380–1387.
[17] M.C.G. Vior, L.E. Dicelio, J. Awruch, Synthesis and properties of phthalocyanine
zinc(II) complexes replaced with oxygen and sulfur linked adamantane moieties,
Dyes Pigm. 83 (2009) 375–380.
[30] In: D.R. Lide (Ed.), CRC Handbook of Chemistry and Physics, 78th edition, CRC
Press LLC, Boca Raton, 1997.
[18] M.C.G. Vior, E. Monteagudo, L.E. Dicelio, J. Awruch, A comparative study of a novel li-
pophilic phthalocyanineincorporated into nanoemulsion formulations: photophysics,
size, solubility and thermodynamic stability, Dyes Pigm. 91 (2011) 208–214.